Trademark: 79327653
Word
CANIFERON
Status
Registered
Status Code
700
Status Date
Tuesday, January 31, 2023
Serial Number
79327653
Registration Number
6966132
Registration Date
Tuesday, January 31, 2023
Mark Type
4000
Filing Date
Thursday, September 16, 2021
Published for Opposition
Tuesday, November 15, 2022

Trademark Owner History
ILC Therapeutics Limited - Original Registrant

Classifications
5 Pharmaceuticals, medical and veterinary preparations for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of skin diseases; pharmaceutical, medical and veterinary preparations for dermatitis; pharmaceutical, medical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancer, skin disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases, for animals; pharmaceutical, medical and veterinary drugs for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biological preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological reagents being pharmaceutical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological tissue cultures for medical use; biochemical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; anti-viral agents; diagnostic preparations for medical and veterinary purposes; clinical diagnostic reagents for medical and veterinary purposes; immunoassay reagents for medical use

Trademark Events
May 30, 2023
Final Decision Transaction Processed By Ib
May 5, 2023
Final Disposition Notice Sent To Ib
May 5, 2023
Final Disposition Processed
Apr 30, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jan 31, 2023
Notice Of Registration Confirmation Emailed
Jan 31, 2023
Registered-Principal Register
Dec 13, 2022
Assigned To Examiner
Nov 15, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 15, 2022
Published For Opposition
Oct 26, 2022
Notification Of Notice Of Publication E-Mailed
Oct 11, 2022
Approved For Pub - Principal Register
Oct 4, 2022
Teas/Email Correspondence Entered
Oct 3, 2022
Correspondence Received In Law Office
Oct 3, 2022
Teas Response To Office Action Received
Jul 19, 2022
Refusal Processed By Ib
Jun 24, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jun 24, 2022
Refusal Processed By Mpu
Jun 22, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 21, 2022
Non-Final Action Written
Jun 21, 2022
Assigned To Examiner
Dec 14, 2021
Application Filing Receipt Mailed
Dec 10, 2021
New Application Office Supplied Data Entered
Dec 9, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24